Medicine Overview of Matropin 2gm/100ml Eye Drop
Introduction
Matropin is used before eye examinations and to treat an eye condition called uveitis. It acts by enlarging the pupil of the eyes and helps the doctor visualize the eye more closely. It reduces redness and swelling in the eyes after cataract surgery. Matropin is for external use only. Use it in the dose and duration as advised by the doctor. Refrain from touching the tip of the dropper to any surface to avoid contaminating the eye drops. Using Matropin can make your eyes more sensitive to light. Thus, wear sunglasses to protect your eyes from sunlight and other bright
Uses of Matropin
- Eye examination
- Uveitis
Side effects of Matropin
Common
- Eye irritation
- Stinging sensation
How to use Matropin
This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid.
How Matropin works
Matropin is used to dilate or enlarge the pupil of the eye so that the doctor can examine the back of the eyeball. It may also be used to reduce pain in certain eye conditions.
What if you forget to take Matropin?
If you miss a dose of Matropin, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Quick Tips
-
Matropin enlarges the pupil for eye examination and is commonly used in children iv>
-
It is also used to relieve eye inflammation (redness and swelling) and infection.
-
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
-
Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
-
Stinging sensation may occur for 1-2 mins. Notify your doctor if it persists for longer.
-
Make sure to use within 4 weeks of opening the bottle.
Brief Description
Indication
Mydriasis and cycloplegia for refraction, Dilatation of pupil
Adult Dose
Ophthalmic
Mydriasis and cycloplegia for refraction
Adult: Instill 1 or 2 drops of 2% solution, may repeat at 10-15 min intervals if necessary; not to exceed 5 doses
Mydriasis and cycloplegia for refraction
Adult: Instill 1 or 2 drops of 2% solution, may repeat at 10-15 min intervals if necessary; not to exceed 5 doses
Uveitis
Adult: Instill 1-2 drops of 2% bid-tid up to every 3-4 hr as needed.
Child Dose
Ophthalmic
Mydriasis and cycloplegia for refraction
Child: Instill 1 drop of 2% soln immediately before the procedure, repeat at 10-min intervals if necessary.
Mydriasis and cycloplegia for refraction
Child: Instill 1 drop of 2% soln immediately before the procedure, repeat at 10-min intervals if necessary.
Uveitis
Child: >2 yr: instill 1 drop of 2% soln bid.
Contraindication
Acute haemorrhage; narrow-angle glaucoma; primary glaucoma; predisposition to glaucoma; hypersensitivity.
Mode of Action
Homatropine, a tertiary amine antimuscarinic, produces dilation and loss of accommodation by blocking the response of iris sphincter muscle and the accommodative ciliary muscle to cholinergic stimulation.
Precaution
Hypertension; cardiac disease; unstable CV status in acute haemorrhage; increased intraocular pressure; obstructive uropathy; paralytic ileus; ulcerative colitis; elderly; infants; young child; pregnancy. Finger pressure should be applied on the lachrymal sac for 1-2 minutes after instillation to reduce systemic absorption.
Lactation: Excretion in milk unknown; not recommended
Side Effect
Blurred vision; photophobia; increased intraocular pressure. Prolonged use may cause local irritation characterized by follicular conjunctivitis, vascular congestion, oedema, exudate and eczematoid dermatitis.
Interaction
Effects may be increased by drugs with antimuscarinic effect such as; some antihistamines; phenothiazines; antipsychotics; TCAs; MAOIs or parasympathomimetics.
Reviews
Clear filtersThere are no reviews yet.